MyFinsight
Home
Blog
About
Contact
Download
Download image
Short-term marketable
securities
$588,753K
Cash and cash
equivalents
$312,012K
Prepaid expenses and
other current assets
$9,590K
Property and equipment,
gross
$14,136K
Total current assets
$910,355K
Operating lease,
right-of-use assets
$18,078K
Property and equipment,
net
$5,457K
Other assets
$3,301K
Restricted cash
$416K
Accumulated depreciation
$8,679K
Total assets
$937,607K
Total liabilities and
stockholders equity
$937,607K
Total stockholders
equity
$636,371K
Total liabilities
$301,236K
Accumulated deficit
-$1,188,420K
Additional paid-in capital
$1,734,882K
Convertible senior notes,
net
$222,895K
Total current
liabilities
$63,953K
Operating lease
liabilities, net of current...
$14,355K
Other liabilities
$33K
Preferred stock,
value-Series ANon Voting...
$53,830K
Preferred stock,
value-Series BNon Voting...
$35,563K
Accumulated other
comprehensive income
$355K
Common stock, 0.001 par
value 300,000,000...
$161K
Accrued expenses and
other current...
$52,902K
Accounts payable
$9,504K
Operating lease
liabilities
$1,547K
Back
Back
Balance Sheet
source: myfinsight.com
Cogent Biosciences, Inc. (COGT)
Cogent Biosciences, Inc. (COGT)